Polymeric Cups for Cavitation-mediated Delivery of Oncolytic Vaccinia Virus

• Published in: Molecular therapy Vol. 24; no. 9; pp. 1627 - 1633
• Main Authors: Myers, Rachel, Coviello, Christian, Erbs, Philippe, Foloppe, Johann, Rowe, Cliff, Kwan, James, Crake, Calum, Finn, Seán, Jackson, Edward, Balloul, Jean-Marc, Story, Colin, Coussios, Constantin, Carlisle, Robert
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2016; Elsevier Limited; Nature Publishing Group
• Subjects: Animals; Cancer; Cavitation; Cell Line, Tumor; Disease Models, Animal; Fluorouracil - pharmacology; Gene expression; Gene Transfer Techniques; Genetic Vectors - administration & dosage; Genetic Vectors - genetics; Humans; Infections; Mice; Neoplasms - genetics; Neoplasms - pathology; Neoplasms - therapy; Oncolytic Virotherapy - methods; Oncolytic Viruses - genetics; Original; Polymerase chain reaction; Transduction, Genetic; Treatment Outcome; Tumor Burden - drug effects; Tumor Burden - genetics; Tumors; Ultrasonic imaging; Vaccinia virus; Vaccinia virus - genetics; Viruses; Xenograft Model Antitumor Assays; United Kingdom > UK; United States > US
• ISSN: 1525-0016; 1525-0024
• DOI: 10.1038/mt.2016.139

Oncolytic viruses (OV) could become the most powerful and selective cancer therapies. However, the limited transport of OV into and throughout tumors following intravenous injection means their clinical administration is often restricted to direct intratumoral dosing. Application of physical stimuli, such as focused ultrasound, offers a means of achieving enhanced mass transport. In particular, shockwaves and microstreaming resulting from the instigation of an ultrasound-induced event known as inertial cavitation can propel OV hundreds of microns. We have recently developed a polymeric cup formulation which, when delivered intravenously, provides the nuclei for instigation of sustained inertial cavitation events within tumors. Here we report that exposure of tumors to focused ultrasound after intravenous coinjection of cups and oncolytic vaccinia virus, leads to substantial and significant increases in activity. When cavitation was instigated within SKOV-3 or HepG2 xenografts, reporter gene expression from vaccinia virus was enhanced 1,000-fold (P < 0.0001) or 10,000-fold (P < 0.001), respectively. Similar increases in the number of vaccinia virus genomes recovered from tumors were also observed. In survival studies, the application of cup mediated cavitation to a vaccinia virus expressing a prodrug converting enzyme provided significant (P < 0.05) retardation of tumor growth. This technology could improve the clinical utility of all biological therapeutics including OV.